Stock Information
Neurocrine Biosciences Inc (NBIX)
Ticker Symbol: NBIX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $13,186.08 mil
Piotroski score: 6
PE Ratio: 26.6427
EPS (TTM): 4.6633
Revenue (TTM): $27.50 M
Dividend Yield: N/A%
ROE: 16.67%
Latest News
-
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential
Mon, Mar 23, 2026 5:37 PM
-
Neurocrine Biosciences Maps 2026 Execution, “Data-Rich” 2027; Ingrezza Guides $2.7B–$2.8B
Sat, Mar 21, 2026 4:03 AM
-
Neurocrine Biosciences Inc (NASDAQ:NBIX) Presents a Compelling Case as a Quality Value Stock
Fri, Mar 20, 2026 12:41 PM
-
Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer
Tue, Mar 17, 2026 8:05 PM
-
Neurocrine Biosciences, Inc. (NBIX) Presents at Stifel 2026 Virtual CNS Forum Transcript
Tue, Mar 17, 2026 6:22 PM
Key Financials
Financial data not available
